Published in J Antimicrob Chemother on December 03, 2010
Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials. PLoS One (2015) 0.81
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. Eur J Clin Microbiol Infect Dis (2011) 0.76
Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy. Eur J Clin Pharmacol (2014) 0.75
A bibliometric analysis of global research production in respiratory medicine. Chest (2005) 4.15
Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J (2008) 3.60
Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med (2010) 3.43
Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol (2009) 3.27
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis (2008) 2.87
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother (2007) 2.79
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med (2007) 2.58
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47
Comparison of amount of biomedical research originating from the European Union and the United States. BMJ (2005) 2.42
Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect (2009) 2.40
Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol (2007) 2.35
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis (2014) 2.29
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg (2008) 2.10
Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis (2008) 2.08
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 2.01
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother (2008) 1.98
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis (2008) 1.91
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother (2007) 1.89
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2005) 1.89
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents (2009) 1.88
Estimates of global production in cardiovascular diseases research. Int J Cardiol (2005) 1.87
Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother (2008) 1.85
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85
Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect (2012) 1.84
Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol (2008) 1.77
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis (2008) 1.75
Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis (2005) 1.74
Unique author identification number in scientific databases: a suggestion. PLoS Med (2006) 1.73
Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69
Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med (2010) 1.67
Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat (2010) 1.66
The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res (2007) 1.65
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol (2005) 1.60
Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.60
Worldwide prevalence of head lice. Emerg Infect Dis (2008) 1.58
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care (2005) 1.58
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother (2008) 1.56
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother (2011) 1.55
Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials. Chest (2007) 1.55
Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care (2009) 1.55
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care (2011) 1.54
Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv (2009) 1.54
Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J (2006) 1.54
Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis (2006) 1.52
Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care (2007) 1.52
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.51
Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50
Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials. Am Heart J (2007) 1.49
Bowel cleansing before bowel surgery: major discordance between evidence and practice. J Gastrointest Surg (2008) 1.45
Do we still need the aminoglycosides? Int J Antimicrob Agents (2008) 1.45
World databases of summaries of articles in the biomedical fields. Arch Intern Med (2007) 1.43
Atelectasis as a cause of postoperative fever: where is the clinical evidence? Chest (2011) 1.41
Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine (Phila Pa 1976) (2008) 1.40
Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Wkly (2008) 1.40
Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother (2006) 1.39
Worldwide trends in quantity and quality of published articles in the field of infectious diseases. BMC Infect Dis (2005) 1.39
From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J (2005) 1.39
Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother (2009) 1.38
Pain and a purple lesion. Am J Med (2006) 1.38
Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci (2010) 1.37
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents (2008) 1.36
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents (2009) 1.35
Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol (2009) 1.34
Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther (2007) 1.34
Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis (2005) 1.33
Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One (2011) 1.33
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents (2012) 1.32
Human infections associated with wild birds. J Infect (2007) 1.29
A bibliometric analysis in the fields of preventive medicine, occupational and environmental medicine, epidemiology, and public health. BMC Public Health (2006) 1.27
Mapping health literacy research in the European Union: a bibliometric analysis. PLoS One (2008) 1.25
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents (2009) 1.23
Infections related to airway stenting: a systematic review. Respiration (2009) 1.21
Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother (2007) 1.21
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med (2011) 1.20
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc (2005) 1.20
Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents (2009) 1.19
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs (2009) 1.19
Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol (2008) 1.18
Treatment of Acinetobacter infections. Expert Opin Pharmacother (2010) 1.18
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med (2007) 1.17
Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg (2006) 1.17
Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol (2010) 1.14
Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents (2008) 1.13
Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol (2007) 1.12
Do psychological variables affect early surgical recovery? PLoS One (2011) 1.11
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One (2012) 1.10